UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 10-Q
(Mark One)
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended December 29, 2012
or
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from to
Commission file number: 000-10030
APPLE INC.
(Exact name of Registrant as specified in its charter)
California
94-2404110
(State or other jurisdiction
of incorporation or organization)
(I.R.S. Employer Identification No.)
1 Infinite Loop
Cupertino, California
95014
(Address of principal executive offices)
(Zip Code)
Registrant s telephone number, including area code: (408) 996-1010
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the
Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.
Yes No
Indicate by check mark whether the registrant has submitted electronically
and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T ( 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the
registrant was required to submit and post such files).
Yes No
Indicate by check mark whether the registrant is a large accelerated filer,
an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act.
Large accelerated filer
Accelerated filer
Non-accelerated filer
(Do not check if a smaller reporting company)
Smaller reporting company
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the
Exchange Act).
Yes No
939,058,000 shares of common stock issued and outstanding as of January 11,
2013
PART I. FINANCIAL INFORMATION
Item 1.
Financial Statements
APPLE INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited)
(In millions, except number of shares which are reflected in thousands and per share amounts)
Three Months Ended
December 29,
2012
December 31,
2011
Net sales
54,512
46,333
Cost of sales
33,452
25,630
Gross margin
21,060
20,703
Operating expenses:
Research and development
1,010
758
Selling, general and administrative
2,840
2,605
Total operating expenses
3,850
3,363
Operating income
17,210
17,340
Other income/(expense), net
462
137
Income before provision for income taxes
17,672
17,477
Provision for income taxes
4,594
4,413
Net income
13,078
13,064
Earnings per share:
Basic
13.93
14.03
Diluted
13.81
13.87
Shares used in computing earnings per share:
Basic
938,916
931,041
Diluted
947,217
941,572
Cash dividends declared per common share
2.65
See accompanying Notes to Condensed Consolidated Financial Statements.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (Unaudited)
(In millions)
Three Months Ended
December 29,
2012
December 31,
2011
Net income
13,078
13,064
Other comprehensive income/(loss):
Change in foreign currency translation, net of tax
(26
(6
Change in unrecognized gains/losses on derivative instruments:
Change in fair value of derivatives, net of tax
146
87
Adjustment for net (gains)/losses realized and included in net income, net of tax
112
(154
Total change in unrecognized gains/losses on derivative instruments
258
(67
Change in unrealized gains/losses on marketable securities:
Change in fair value of marketable securities, net of tax
(66
27
Adjustment for net (gains)/losses realized and included in net income, net of tax
(53
(13
Total change in unrealized gains/losses on marketable securities, net of tax
(119
14
Total other comprehensive income/(loss)
113
(59
Total comprehensive income
13,191
13,005
See accompanying Notes to Condensed Consolidated Financial Statements.
APPLE INC.
CONDENSED CONSOLIDATED BALANCE SHEETS (Unaudited)
(In millions, except number of shares which are reflected in thousands)
December 29,
2012
September 29,
2012
ASSETS:
Current assets:
Cash and cash equivalents
16,154
10,746
Short-term marketable securities
23,666
18,383
Accounts receivable, less allowances of $119 and $98, respectively
11,598
10,930
Inventories
1,455
791
Deferred tax assets
2,895
2,583
Vendor non-trade receivables
9,936
7,762
Other current assets
6,644
6,458
Total current assets
72,348
57,653
Long-term marketable securities
97,292
92,122
Property, plant and equipment, net
15,422
15,452
Goodwill
1,381
1,135
Acquired intangible assets, net
4,462
4,224
Other assets
5,183
5,478
Total assets
196,088
176,064
LIABILITIES AND SHAREHOLDERS EQUITY:
Current liabilities:
Accounts payable
26,398
21,175
Accrued expenses
13,207
11,414
Deferred revenue
7,274
5,953
Total current liabilities
46,879
38,542
Deferred revenue - non-current
2,938
2,648
Other non-current liabilities
18,925
16,664
Total liabilities
68,742
57,854
Commitments and contingencies
Shareholders equity:
Common stock, no par value; 1,800,000 shares authorized; 938,973 and 939,208 shares issued and outstanding,
respectively
17,167
16,422
Retained earnings
109,567
101,289
Accumulated other comprehensive income
612
499
Total shareholders equity
127,346
118,210
Total liabilities and shareholders equity
196,088
176,064
See accompanying Notes to Condensed Consolidated Financial Statements.
APPLE INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited)
(In millions)
Three Months Ended
December 29,
2012
December 31,
2011
Cash and cash equivalents, beginning of the period
10,746
9,815
Operating activities:
Net income
13,078
13,064
Adjustments to reconcile net income to cash generated by operating activities:
Depreciation and amortization
1,588
721
Share-based compensation expense
545
420
Deferred income tax expense
1,179
1,456
Changes in operating assets and liabilities:
Accounts receivable, net
(668
(3,561
Inventories
(664
(460
Vendor non-trade receivables
(2,174
(1,206
Other current and non-current assets
413
(962
Accounts payable
6,145
4,314
Deferred revenue
1,611
1,296
Other current and non-current liabilities
2,373
2,472
Cash generated by operating activities
23,426
17,554
Investing activities:
Purchases of marketable securities
(37,192
(40,175
Proceeds from maturities of marketable securities
3,460
3,038
Proceeds from sales of marketable securities
23,002
21,472
Payments made in connection with business acquisitions, net
(284
Payments for acquisition of property, plant and equipment
(2,317
(1,321
Payments for acquisition of intangible assets
(138
(108
Other
(52
(34
Cash used in investing activities
(13,521
(17,128
Financing activities:
Proceeds from issuance of common stock
76
91
Excess tax benefits from equity awards
404
333
Dividends and dividend equivalent rights paid
(2,493
Repurchase of common stock
(1,950
Taxes paid related to net share settlement of equity awards
(534
(355
Cash (used in)/generated by financing activities
(4,497
69
Increase in cash and cash equivalents
5,408
495
Cash and cash equivalents, end of the period
16,154
10,310
Supplemental cash flow disclosure:
Cash paid for income taxes, net
1,890
1,474
See accompanying Notes to Condensed Consolidated Financial Statements.
Apple Inc.
Notes to Condensed Consolidated Financial Statements (Unaudited)
Note 1 Summary of Significant Accounting Policies
Apple Inc. and its wholly-owned subsidiaries (collectively Apple or the Company ) designs,
manufactures, and markets mobile communication and media devices, personal computers, and portable digital music players, and sells a variety of related software, services, peripherals, networking solutions, and third-party digital content and
applications. The Company sells its products worldwide through its retail stores, online stores, and direct sales force, as well as through third-party cellular network carriers, wholesalers, retailers and value-added resellers. In addition, the
Company sells a variety of third-party iPhone, iPad, Mac, and iPod compatible products, including application software, and various accessories through its online and retail stores. The Company sells to consumers, small and mid-sized businesses, and
education, enterprise and government customers.
Basis of Presentation and Preparation
The accompanying condensed consolidated financial statements include the accounts of the Company. Intercompany accounts and transactions
have been eliminated. The preparation of these condensed consolidated financial statements in conformity with U.S. generally accepted accounting principles ( GAAP ) requires management to make estimates and assumptions that affect the
amounts reported in these condensed consolidated financial statements and accompanying notes. Actual results could differ materially from those estimates. Certain prior period amounts in the condensed consolidated financial statements and notes
thereto have been reclassified to conform to the current period s presentation.
These condensed consolidated financial
statements and accompanying notes should be read in conjunction with the Company s annual consolidated financial statements and the notes thereto for the fiscal year ended September 29, 2012, included in its Annual Report on Form 10-K (the
2012 Form 10-K ). The Company s fiscal year is the 52 or 53-week period that ends on the last Saturday of September. The Company s fiscal year 2013 will include 52 weeks, whereas fiscal year 2012 included 53 weeks. An additional
week was included in the first quarter of 2012 to realign the Company s fiscal quarters more closely to calendar quarters. Unless otherwise stated, references to particular years, quarters or months refer to the Company s fiscal years
ended in September and the associated quarters or months of those fiscal years.
During the first quarter of 2013, the Company
adopted amended accounting standards that change the presentation of comprehensive income. These standards increase the prominence of other comprehensive income ( OCI ) by eliminating the option to present components of OCI as part of the
statement of changes in shareholders equity and requires the components of OCI to be presented either in a single continuous statement of comprehensive income or in two consecutive statements. The amended accounting standards only impact the
financial statement presentation of OCI and do not change the components that are recognized in net income or OCI; accordingly, the adoption had no impact on the Company s financial position or results of operations.
Earnings Per Share
Basic earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of
common stock outstanding during the period. Diluted earnings per share is computed by dividing income available to common shareholders by the weighted-average number of shares of common stock outstanding during the period increased to include the
number of additional shares of common stock that would have been outstanding if the potentially dilutive securities had been issued. Potentially dilutive securities include outstanding stock options, shares to be purchased under the Company s
employee stock purchase plan and unvested restricted stock units ( RSUs ). The dilutive effect of potentially dilutive securities is reflected in diluted earnings per share by application of the treasury stock method. Under the treasury
stock method, an increase in the fair market value of the Company s common stock can result in a greater dilutive effect from potentially dilutive securities.
The following table shows the computation of basic and diluted earnings per share for the
three months ended December 29, 2012 and December 31, 2011 (in thousands, except net income in millions and per share amounts):
Three Months Ended
December 29,
2012
December 31,
2011
Numerator:
Net income
13,078
13,064
Denominator:
Weighted-average shares outstanding
938,916
931,041
Effect of dilutive securities
8,301
10,531
Weighted-average diluted shares
947,217
941,572
Basic earnings per share
13.93
14.03
Diluted earnings per share
13.81
13.87
Potentially dilutive securities representing 3.7 million shares of common stock for the three months
ended December 29, 2012, were excluded from the computation of diluted earnings per common share because their effect would have been antidilutive. The number of potentially dilutive securities excluded from the computation of diluted earnings
per common share because their effect would have been antidilutive was not significant for the three months ended December 31, 2011.
Note 2 Financial Instruments
Cash, Cash Equivalents and Marketable Securities
The following tables show the Company s cash and available-for-sale securities adjusted cost, gross unrealized gains, gross unrealized losses and fair value by significant investment category
recorded as cash and cash equivalents or short- or long-term marketable securities as of December 29, 2012 and September 29, 2012 (in millions):
December 29, 2012
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Short-Term
Marketable
Securities
Long-Term
Marketable
Securities
Cash
7,080
7,080
7,080
Level 1 (a):
Money market funds
3,666
3,666
3,666
Mutual funds
3,682
27
(45
3,664
3,664
Subtotal
7,348
27
(45
7,330
3,666
3,664
Level 2 (b):
U.S. Treasury securities
22,890
21
(2
22,909
1,335
6,427
15,147
U.S. agency securities
20,658
45
(3
20,700
1,592
3,478
15,630
Non-U.S. government securities
4,684
186
(3
4,867
63
741
4,063
Certificates of deposit and time deposits
2,370
2,371
1,384
224
763
Commercial paper
2,079
2,079
906
1,029
144
Corporate securities
49,390
554
(15
49,929
117
7,407
42,405
Municipal securities
6,053
58
(7
6,104
11
695
5,398
Mortgage- and asset-backed securities
13,696
59
(12
13,743
13,742
Subtotal
121,820
924
(42
122,702
5,408
20,002
97,292
Total
136,248
951
(87
137,112
16,154
23,666
97,292
September 29, 2012
Adjusted
Cost
Unrealized
Gains
Unrealized
Losses
Fair
Value
Cash and
Cash
Equivalents
Short-Term
Marketable
Securities
Long-Term
Marketable
Securities
Cash
3,109
3,109
3,109
Level 1 (a):
Money market funds
1,460
1,460
1,460
Mutual funds
2,385
79
(2
2,462
2,462
Subtotal
3,845
79
(2
3,922
1,460
2,462
Level 2 (b):
U.S. Treasury securities
20,088
21
(1
20,108
2,608
3,525
13,975
U.S. agency securities
19,540
58
(1
19,597
1,460
1,884
16,253
Non-U.S. government securities
5,483
183
(2
5,664
84
1,034
4,546
Certificates of deposit and time deposits
2,189
2,191
1,106
202
883
Commercial paper
2,112
2,112
909
1,203
Corporate securities
46,261
568
(8
46,821
10
7,455
39,356
Municipal securities
5,645
74
5,719
618
5,101
Mortgage- and asset-backed securities
11,948
66
(6
12,008
12,008
Subtotal
113,266
972
(18
114,220
6,177
15,921
92,122
Total
120,220
1,051
(20
121,251
10,746
18,383
92,122
(a)
The fair value of Level 1 securities is estimated based on quoted prices in active markets for identical assets or liabilities.
(b)
The fair value of Level 2 securities is estimated based on observable inputs other than quoted prices in active markets for identical assets and
liabilities, quoted prices for identical or similar assets or liabilities in inactive markets, or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
The net unrealized gains as of December 29, 2012 and September 29, 2012 are related primarily to
long-term marketable securities. The Company may sell certain of its marketable securities prior to their stated maturities for strategic reasons including, but not limited to, anticipation of credit deterioration and duration management. The net
realized gains or losses recognized by the Company related to such sales were not significant during the three months ended December 29, 2012 and December 31, 2011. The maturities of the Company s long-term marketable securities
generally range from one to five years.
As of December 29, 2012 and September 29, 2012, gross unrealized losses
related to individual securities that had been in a continuous loss position for 12 months or longer were not significant.
As
of December 29, 2012, the Company considers the declines in market value of its marketable securities investment portfolio to be temporary in nature and does not consider any of its investments other-than-temporarily impaired. The Company
typically invests in highly-rated securities, and its investment policy generally limits the amount of credit exposure to any one issuer. The policy requires investments generally to be investment grade, with the primary objective of minimizing the
potential risk of principal loss. Fair values were determined for each individual security in the investment portfolio. When evaluating an investment for other-than-temporary impairment, the Company reviews factors such as the length of time and
extent to which fair value has been below its cost basis, the financial condition of the issuer and any changes thereto, and the Company s intent to sell, or whether it is more likely than not it will be required to sell, the investment before
recovery of the investment s cost basis. During the three months ended December 29, 2012 and December 31, 2011, the Company did not recognize any significant impairment charges.
Derivative Financial Instruments
The Company uses derivatives to partially offset its business exposure to foreign currency exchange risk. The Company may enter into
foreign currency forward and option contracts to offset some of the foreign exchange risk on expected future cash flows on certain forecasted revenue and cost of sales, on net investments in certain foreign subsidiaries, and on certain existing
assets and liabilities.
To help protect gross margins from fluctuations in foreign currency exchange rates, certain of the
Company s subsidiaries whose functional currency is the U.S. dollar hedge a portion of forecasted foreign currency revenue. The Company s subsidiaries whose functional currency is not the U.S. dollar and who sell in local currencies may
hedge a portion of forecasted inventory purchases not denominated in the subsidiaries functional currencies. The Company typically hedges portions of its forecasted foreign currency exposure associated with revenue and inventory purchases
generally up to six months.
To help protect the net investment in a foreign operation from adverse changes in foreign
currency exchange rates, the Company may enter into foreign currency forward and option contracts to offset the changes in the carrying amounts of these investments due to fluctuations in foreign currency exchange rates.
The Company may also enter into foreign currency forward and option contracts to partially offset the foreign currency exchange gains and
losses generated by the re-measurement of certain assets and liabilities denominated in non-functional currencies. However, the Company may choose not to hedge certain foreign currency exchange exposures for a variety of reasons including, but not
limited to, accounting considerations and the prohibitive economic cost of hedging particular exposures. There can be no assurance the hedges will offset more than a portion of the financial impact resulting from movements in foreign currency
exchange rates.
The Company records all derivatives in the Condensed Consolidated Balance Sheets at fair value. The
Company s accounting treatment of these instruments is based on whether the instruments are designated as hedge or non-hedge instruments. The effective portions of cash flow hedges are recorded in accumulated other comprehensive income
( AOCI ) until the hedged item is recognized in earnings. The effective portions of net investment hedges are recorded in OCI as a part of the cumulative translation adjustment. The ineffective portions of cash flow hedges and net
investment hedges are recorded in other income and expense. Derivatives that are not designated as hedging instruments are adjusted to fair value through earnings in the financial statement line item to which the derivative relates.
The Company s net deferred gain associated with cash flow hedges was not significant as of December 29, 2012. The Company had a
net deferred loss associated with cash flow hedges of $240 million, net of taxes, recorded in AOCI as of September 29, 2012. Deferred gains and losses associated with cash flow hedges of foreign currency revenue are recognized as a component of
net sales in the same period as the related revenue is recognized, and deferred gains and losses related to cash flow hedges of inventory purchases are recognized as a component of cost of sales in the same period as the related costs are
recognized. The majority of the Company s hedged transactions as of December 29, 2012 are expected to occur within six months.
Derivative instruments designated as cash flow hedges must be de-designated as hedges when it is probable the forecasted hedged transaction will not occur in the initially identified time period or within
a subsequent two-month time period. Deferred gains and losses in AOCI associated with such derivative instruments are reclassified immediately into other income and expense. Any subsequent changes in fair value of such derivative instruments are
reflected in other income and expense unless they are re-designated as hedges of other transactions. The Company did not recognize any significant net gains or losses related to the loss of hedge designation on discontinued cash flow hedges during
the three months ended December 29, 2012 and December 31, 2011.
The Company s unrealized net gains and losses
on net investment hedges, included in the cumulative translation adjustment account of AOCI, were not significant as of December 29, 2012 and September 29, 2012, respectively. The ineffective portions of and amounts excluded from the
effectiveness test of net investment hedges are recorded in other income and expense.
The gain/loss recognized in other income and expense for foreign currency forward and option
contracts not designated as hedging instruments was not significant during the three months ended December 29, 2012 and December 31, 2011, respectively. These amounts represent the net gain or loss on the derivative contracts and do not
include changes in the related exposures, which generally offset a portion of the gain or loss on the derivative contracts.
The following table shows the notional principal amounts of the Company s outstanding derivative instruments and credit risk amounts
associated with outstanding or unsettled derivative instruments as of December 29, 2012 and September 29, 2012 (in millions):
December 29, 2012
September 29, 2012
Notional
Principal
Credit Risk
Amounts
Notional
Principal
Credit Risk
Amounts
Instruments designated as accounting hedges:
Foreign exchange contracts
33,012
455
41,970
140
Instruments not designated as accounting hedges:
Foreign exchange contracts
31,241
184
13,403
12
The notional principal amounts for outstanding derivative instruments provide one measure of the
transaction volume outstanding and do not represent the amount of the Company s exposure to credit or market loss. The credit risk amounts represent the Company s gross exposure to potential accounting loss on derivative instruments that
are outstanding or unsettled if all counterparties failed to perform according to the terms of the contract, based on then-current currency exchange rates at each respective date. The Company s gross exposure on these transactions may be
further mitigated by collateral received from certain counterparties. The Company s exposure to credit loss and market risk will vary over time as a function of currency exchange rates. Although the table above reflects the notional principal
and credit risk amounts of the Company s foreign exchange instruments, it does not reflect the gains or losses associated with the exposures and transactions that the foreign exchange instruments are intended to hedge. The amounts ultimately
realized upon settlement of these financial instruments, together with the gains and losses on the underlying exposures, will depend on actual market conditions during the remaining life of the instruments.
The Company generally enters into master netting arrangements, which reduce credit risk by permitting net settlement of transactions with
the same counterparty. To further limit credit risk, the Company generally enters into collateral security arrangements that provide for collateral to be received or posted when the net fair value of certain financial instruments fluctuates from
contractually established thresholds. The Company presents its derivative assets and derivative liabilities at their gross fair values. As of December 29, 2012, the Company posted $78 million of cash collateral and received $222 million of cash
collateral related to the derivative instruments under its collateral security arrangements, which were recorded as other current assets and accrued expenses in the Condensed Consolidated Balance Sheet, respectively. As of September 29, 2012,
the Company posted cash collateral related to the derivative instruments under its collateral security arrangements of $278 million, which it recorded as other current assets in the Condensed Consolidated Balance Sheet. The Company did not have
any derivative instruments with credit-risk related contingent features that would require it to post additional collateral as of December 29, 2012 or September 29, 2012.
10
The following tables show the Company s derivative instruments at gross fair value as
reflected in the Condensed Consolidated Balance Sheets as of December 29, 2012 and September 29, 2012 (in millions):
December 29, 2012
Fair Value of
Derivatives
Designated
as Hedge
Instruments
Fair Value of
Derivatives
Not Designated
as Hedge
Instruments
Total
Fair Value
Derivative assets (a):
Foreign exchange contracts
449
184
633
Derivative liabilities (b):
Foreign exchange contracts
275
232
507
September 29, 2012
Fair Value of
Derivatives
Designated
as Hedge
Instruments
Fair Value of
Derivatives
Not Designated
as Hedge
Instruments
Total
Fair Value
Derivative assets (a):
Foreign exchange contracts
138
12
150
Derivative liabilities (b):
Foreign exchange contracts
516
41
557
(a)
The fair value of derivative assets is measured using Level 2 fair value inputs and is recorded as other current assets in the Condensed
Consolidated Balance Sheets.
(b)
The fair value of derivative liabilities is measured using Level 2 fair value inputs and is recorded as accrued expenses in the Condensed
Consolidated Balance Sheets.
11
The following table shows the pre-tax effect of the Company s derivative instruments
designated as cash flow and net investment hedges in the Condensed Consolidated Statements of Operations for the three months ended December 29, 2012 and December 31, 2011 (in millions):